Your browser doesn't support javascript.
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.
Trunfio, Mattia; Salvador, Elena; Cabodi, Daniela; Marinaro, Letizia; Alcantarini, Chiara; Gaviraghi, Alberto; Trentalange, Alice; Lipani, Filippo; Sciascia, Savino; Roccatello, Dario; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea.
  • Trunfio M; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy. Electronic address: mattia.trunfio@edu.unito.it.
  • Salvador E; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Cabodi D; Laboratory Analysis, San Giovanni Bosco Hospital, ASL Città di Torino, Torino, Italy.
  • Marinaro L; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Alcantarini C; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Gaviraghi A; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Trentalange A; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Lipani F; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Sciascia S; Center of Research of Immunopathology and Rare Diseases-CMID, Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, Nephrology and Dialysis Division (ERKnet member), Department of Clinical and Biological Sciences, University of Turin, San Giovanni Bosco Hospital, Turin,
  • Roccatello D; Center of Research of Immunopathology and Rare Diseases-CMID, Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, Nephrology and Dialysis Division (ERKnet member), Department of Clinical and Biological Sciences, University of Turin, San Giovanni Bosco Hospital, Turin,
  • Bonora S; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Di Perri G; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
  • Calcagno A; Department of Medical Sciences, University of Torino at Infectious Diseases Unit, Amedeo di Savoia Hospital, Torino, Italy.
Thromb Res ; 196: 432-434, 2020 12.
Article in English | MEDLINE | ID: covidwho-836871
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Blood Coagulation / Factor Xa / Drug Monitoring / Enoxaparin / Heparin, Low-Molecular-Weight / COVID-19 Drug Treatment / Anticoagulants Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Thromb Res Year: 2020 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / Blood Coagulation / Factor Xa / Drug Monitoring / Enoxaparin / Heparin, Low-Molecular-Weight / COVID-19 Drug Treatment / Anticoagulants Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Thromb Res Year: 2020 Document Type: Article